Article
Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose.
Journal of the American Heart Association - 13 Feb 2018
Tang Xian-Liang, Nakamura Shunichi, Li Qianhong, Wysoczynski Marcin, Gumpert Anna M, Wu Wen-Jian, Hunt Greg, Stowers Heather, Ou Qinghui, Bolli Roberto
Abstract excerpt
BACKGROUND: We have recently found that 3 repeated doses (12×106 each) of c-kitPOS cardiac progenitor cells (CPCs) were markedly more effective than a single dose of 12×106 cells in alleviating postinfarction left ventricular dysfunction and remodeling. However, since the single-dose group received only one third of the total number of CPCs given to the multiple-dose group, it is unknown whether the superior...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
